Wells Fargo
ZSAN

Wells Fargo’s Zosano Pharma Corporation ZSAN Stock Holding History

Wells Fargo’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-68
Closed -$1K – 8019
2022
Q1 		$1K Buy
68
+10
+17% +$110 ﹤0.01% 6945
2021
Q4 		$1K Buy
58
+2
+4% +$42 ﹤0.01% 7143
2021
Q3 		$1K Sell
56
-1
-2% -$26 ﹤0.01% 6886
2021
Q2 		$2K Buy
57
+38
+200% +$1.23K ﹤0.01% 6597
2021
Q1 		$1K Buy
19
+4
+27% +$168 ﹤0.01% 6819
2020
Q4 		$0 Buy
15
+3
+25% +$59 ﹤0.01% 7324
2020
Q3 		$1K Buy
12
+3
+33% +$140 ﹤0.01% 6264
2020
Q2 		$0 Buy
9
+5
+125% +$141 ﹤0.01% 7102
2020
Q1 		$0 Buy
+4
New +$134 ﹤0.01% 7109
2016
Q3 		– Hold
0
– – – 6425
2016
Q2 		– Hold
0
– – – 6434
2016
Q1 		– Hold
0
– – – 6532
2015
Q4 		– Hold
0
– – – 6500
2015
Q3 		– Hold
0
– – – 6543

Other funds holding ZSAN

CDIA
Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Wells Fargo's ZSAN Position: Q2 2022 in Review

Wells Fargo sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 68 shares — an estimated $1K sold.

Wells Fargo first reported a position in ZSAN in Q1 2020 and held it in 9 quarters. The position peaked at $2K in Q2 2021. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

  • Wells Fargo reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
  • Wells Fargo sold 68 Zosano Pharma Corporation shares in Q2 2022, an estimated $1K.
  • Wells Fargo first reported a position in Zosano Pharma Corporation in Q1 2020 and held it in 9 quarters.
  • Wells Fargo's Zosano Pharma Corporation position peaked at $2K in Q2 2021.
  • 3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Wells Fargo's 13F filing for Q2 2022, filed 12 Aug 2022.